Neurología, Clase 11

Memory Types and Their Functions

Overview of Memory

• The discussion begins with the classification of memory into immediate, short-term, and long-term types.

• Immediate memory allows a person to repeat information right after hearing it, while short-term memory retains information for a few minutes.

• Long-term memory requires hours or days to store information and can last for weeks or months.

Long-Term Memory Subtypes

• Long-term memory is divided into explicit (declarative) and implicit (non-declarative) memories.

Explicit (Declarative) Memory

• Explicit memory includes spatial memory for orientation in time and space, episodic memory for autobiographical events, and semantic memory for general knowledge about the world.

• Semantic memories are facts learned over time; they require conscious recall when asked questions like "What is the capital of Peru?"

Brain Areas Involved

• The hippocampus and medial temporal lobe are crucial for processing spatial and episodic memories.

Implicit (Non-declarative) Memory

• Implicit memory operates without conscious thought; it involves automatic processes such as procedural skills learned through repetition.

• Procedural memories include tasks like driving a car or riding a bicycle, which are stored in the basal ganglia.

Summary of Brain Structures

Understanding Memory Types and Their Implications

Procedural Memory and Its Mechanisms

• Procedural memory is associated with the basal ganglia and cerebellum, responsible for automatic tasks like driving or cycling. This type of memory allows actions to be performed unconsciously after initial learning.

• Initially, when learning a new skill (e.g., driving), individuals rely on semantic memory to process information rather than procedural memory, which develops over time as skills become more automatic.

Implicit Memory: Priming and Conditioning

• Priming is a form of implicit memory where previous experiences influence future actions automatically, such as writing in cursive after having learned it previously. This occurs without conscious thought.

• Classical conditioning, exemplified by Pavlov's dogs, demonstrates how a neutral stimulus can become associated with an unconditioned stimulus (like food) to elicit a conditioned response (salivation). This principle applies to both animals and humans.

Emotional Memory and Basic Forms of Learning

• The amygdala plays a crucial role in emotional memories and is linked to the hippocampus; it helps associate stimuli with emotional responses through conditioning processes.

• Habituation and sensitization are primitive forms of memory observed even in simple organisms like bacteria, involving reflex pathways that adjust responses based on repeated exposure to stimuli (e.g., pain).

Alzheimer's Disease Impact on Memory

• Alzheimer's primarily affects explicit memory types at onset, particularly episodic memory—leading individuals to forget daily activities or where they placed items. This early symptom highlights the disease's impact on short-term recall abilities.

• As Alzheimer's progresses, spatial awareness also deteriorates; patients may lose track of time or their location due to impaired episodic and spatial memories. Eventually, semantic memory suffers as well—individuals forget concepts or names associated with objects.

Long-Term Memory Classification

Memory Types and Alzheimer's Disease

Understanding Memory Types

• Immediate memory is described as the ability to recall information within seconds. It transitions into working memory, which lasts from seconds to minutes.

• Working memory is a special type of short-term memory that involves actively using information, such as remembering a phone number long enough to dial it.

• The frontal lobe is primarily responsible for working memory, where recent information is temporarily stored for immediate use.

• Information enters the brain through sensory receptors (visual, auditory, etc.) and must be encoded before it can transition from short-term to long-term memory.

• Long-term memory develops when important information is repeated or consolidated after being initially encoded.

Alzheimer’s Disease Overview

• Alzheimer’s disease was first identified by German physician Alois Alzheimer in 1906 when he observed symptoms in a 57-year-old female patient who experienced forgetfulness and hallucinations.

• Over time, the condition progressed from independence to complete dependence on others for care until her death.

• By 1920, the disease was named "Alzheimer's" in honor of its discoverer; research has since advanced regarding diagnosis and treatment options.

Current Understanding and Treatment Approaches

• Initially considered untreatable due to its neurodegenerative nature, research has focused on understanding brain deterioration associated with Alzheimer's over the years.

• In 2014, clinical trials began exploring treatments aimed at slowing disease progression; however, no specific cure exists yet.

Cognitive Impairment and Behavioral Changes

• Alzheimer's leads to cognitive decline characterized by issues with memory and learning alongside behavioral changes that affect social interactions and work performance.

• Significant cognitive impairment results in social and occupational dysfunction; unlike occasional forgetfulness, dementia severely impacts daily functioning.

Brain Imaging Insights

Understanding Hippocampal Atrophy and Alzheimer's Disease

Hippocampal Changes in Dementia

• The hippocampus shows signs of atrophy, indicated by increased liquid density in imaging. This suggests a smaller size compared to healthy brains.

• Comparison between the right and left hippocampi reveals that the right side is more atrophied, correlating with cognitive decline.

Brain Structure and Dementia

• Enlarged sulci (brain grooves) are observed due to increased cerebrospinal fluid, indicating brain shrinkage associated with dementia.

• A biopsy of a dementia patient's brain shows significant atrophy, highlighting the physical changes accompanying cognitive impairment.

Memory Consolidation Failure

• In dementia, particularly Alzheimer’s disease, there is a failure in memory consolidation—the process of transferring short-term memories into long-term storage. This primarily affects the hippocampus.

Prevalence and Risk Factors for Alzheimer's Disease

• The prevalence of Alzheimer’s increases with age; approximately 6% to 10% of individuals over 65 are affected, rising significantly in older age groups (up to 39% for those aged 90-95).

• While most cases are sporadic among older adults, about 10% can occur in younger individuals due to genetic predispositions. Genes like APOE E4 increase risk significantly—up to 50% for men and up to 60% for women carrying this allele.

Modifiable vs Non-modifiable Risk Factors

• Non-modifiable factors include age and gender; women have a higher incidence of Alzheimer’s than men. Genetic factors such as having the APOE E4 genotype also fall under this category.

Understanding Alzheimer's Disease and Risk Factors

Genetic and Environmental Risk Factors

• The transcript discusses how Down syndrome is a genetic risk factor for Alzheimer’s disease, linked to alterations in chromosome 21 that predispose individuals to develop the condition.

• Other significant risk factors include family history, specific genotypes, obesity, insulin resistance, vascular issues, dyslipidemia, hypertension, inflammatory markers, traumatic brain injury, and Down syndrome.

Lifestyle and Health Conditions Impacting Alzheimer's

• Sleep disturbances and poor sleep quality are identified as additional risk factors for developing Alzheimer’s. Depression and diabetes also contribute to increased risk.

• Previous cerebrovascular diseases, hyperhomocysteinemia (high levels of homocysteine), obesity, atrial fibrillation, carotid artery alterations (atheromas), smoking habits, hypertension, traumatic injuries, alcohol consumption, vitamin C deficiency, lack of exercise, poor diet quality, and low cognitive activity are all noted as contributing factors.

Cognitive Reserve and Education's Role

• The concept of "cognitive reserve" is introduced; it refers to the brain's ability to retain information acquired over time. Higher education levels correlate with greater cognitive reserve.

• Individuals with lower educational attainment may exhibit more pronounced symptoms of Alzheimer’s due to reduced cognitive reserve compared to those with higher education levels.

Pathophysiology of Alzheimer's Disease

• The discussion shifts towards the pathophysiology of Alzheimer’s disease involving amyloid precursor protein (APP), which plays a role in neuronal communication and neuroplasticity.

• APP is found in neuron membranes but its exact function remains unclear; it may influence neurotransmitter release and enhance neuronal connectivity.

Amyloid Beta Formation Mechanism

• APP undergoes cleavage by enzymes known as secretases. There are two types: one cuts at an external domain while the other operates within the membrane.

• An imbalance in secretase activity can lead to excessive production of amyloid beta 42 (Aβ42), which is less soluble than other forms like Aβ39 or Aβ40. This accumulation leads to plaque formation outside neurons.

Consequences of Amyloid Accumulation

• Aβ42 plaques accumulate between neurons disrupting synaptic communication essential for neuronal health.

Understanding the Pathophysiology of Alzheimer's Disease

Neuronal Structure and Function

• The neuron consists of a neuronal body (soma) and an axon, which is essential for communication between neurons.

• Microtubules within the axon act as pathways for transporting substances like proteins from the soma to the axon terminal.

Impact of Alzheimer's Disease on Microtubules

• In Alzheimer's disease, microtubules deteriorate due to hyperphosphorylation of a protein called Tau, which normally stabilizes these structures.

• Hyperphosphorylated Tau leads to disintegration of microtubules, disrupting transport and communication within neurons.

Consequences of Neuronal Communication Failure

• If communication fails due to damaged microtubules, neurons cannot function properly and may eventually die.

• The degeneration occurs both from internal factors (Tau alteration) and external factors (accumulation of amyloid plaques).

Amyloid Plaques and Their Role in Alzheimer’s Disease

• Amyloid plaques accumulate outside neurons, hindering their ability to communicate through various synaptic connections.

• These plaques are difficult to eliminate because they are large and interfere with neuronal signaling.

Cascading Effects Leading to Neurodegeneration

• Accumulation of amyloid beta 42 contributes to plaque formation outside neurons while also affecting Tau inside neurons.

• This results in neurofibrillary tangles that further disrupt transport mechanisms within the neuron.

Inflammatory Response Triggered by Amyloid Accumulation

• The presence of amyloid plaques activates microglia, which attempt to clear them but lead to inflammation instead.

• This inflammatory response generates pro-inflammatory factors that can produce toxic substances detrimental to neuronal health.

Final Outcomes in Alzheimer’s Pathophysiology

• Increased inflammation leads to cellular damage through toxic substances like free radicals, ultimately resulting in neuronal death.

Understanding Alzheimer's Disease: Memory Impairment and Neurological Changes

Initial Effects on the Brain

• The death of neurons leads to cerebral atrophy, with the hippocampus in the temporal lobe being the first area affected.

• Early memory issues in Alzheimer’s patients primarily involve short-term memory, specifically episodic memory rather than semantic memory.

Types of Memory Affected

• The accumulation of amyloid and tau proteins initially occurs in the hippocampus, impacting episodic memory related to personal experiences.

• Patients may forget recent events or where they placed items, indicating a decline in spatial awareness and orientation over time.

Progression of Memory Loss

• As Alzheimer’s progresses, semantic memory is also affected due to widespread cortical changes, leading to forgotten learned concepts.

• Implicit memories (e.g., riding a bike or driving a car) deteriorate as procedural memory linked to basal ganglia and cerebellum is compromised.

Cognitive Decline and Dementia

• The gradual accumulation of amyloid and tau results in cognitive decline that affects daily functional activities, ultimately leading to dementia.

Role of Amyloid Proteins

• Beta-amyloid proteins are involved in neuronal communication but can lead to Alzheimer’s when they accumulate abnormally.

• These proteins form oligomers that take about 20 years from initial abnormal accumulation to symptom onset.

Inflammatory Response and Neuronal Death

• Oligomers develop into fibrils and plaques; microglial cells trigger inflammatory responses that destabilize axonal transport systems.

• Neuronal communication fails due to these alterations, resulting in neuron death which contributes further to brain atrophy.

Genetic Factors Influencing Alzheimer's Disease

• Genetic mutations associated with early-onset Alzheimer’s include presenilin 1 and 2; these account for less than 5% of cases but have significant familial implications.

Risk Factors for Development

• Alterations in specific genes increase the risk of developing Alzheimer’s significantly if present.

Common Symptoms

Understanding Progressive Dementia

Overview of Dementia Variants

• The discussion begins with the clarification that certain types of dementia can be confused with other forms, highlighting the rarity of some variants.

• It is emphasized that dementia is a progressive disease, characterized by mild, moderate, and severe stages.

Preclinical Stage of Cognitive Decline

• The preclinical stage involves forgetfulness without significant functional impairment; individuals may notice their memory lapses but continue to function normally in daily life.

• Memory loss is identified as the primary visible sign during this preclinical phase, termed mild cognitive impairment (MCI), specifically amnesic type.

• Physical and neurological examinations typically yield normal results despite minor cognitive test alterations.

Anatomical Changes Before Symptoms

• Anatomical changes such as hippocampal shrinkage are observed even before symptoms manifest; these changes can occur up to 20 years prior to noticeable cognitive decline.

• Accumulation of amyloid-beta and tau proteins in the brain precedes symptom onset, indicating underlying pathological processes.

Early Stages of Alzheimer's Disease

• In early Alzheimer's stages, episodic memory loss becomes apparent; individuals struggle with recalling daily events or misplacing items.

• Confusion regarding familiar locations and increased time taken for daily tasks signal a decline from mild cognitive impairment to early dementia.

Progression to Moderate Dementia

• As dementia progresses to a moderate stage, there is an increase in memory loss and confusion about friends and family members' identities.

• Language difficulties arise alongside challenges in reading, writing, and numerical tasks; learning new information becomes increasingly difficult.

Behavioral Changes Associated with Dementia

• Individuals may exhibit agitation, anxiety, emotional distress including crying spells, especially during late hours.

• Motor disturbances may develop along with delusions or paranoia about being harmed or robbed.

Understanding Paranoia and Cognitive Decline

Symptoms of Paranoia

• Individuals may exhibit signs of jealousy or suspicion towards their partners without concrete evidence, leading to a state of paranoia. This can manifest as irritability and hallucinations, both visual and auditory.

Behavioral Changes

• Observable behaviors include inappropriate dressing, use of vulgar language, and motor perceptual difficulties such as trouble standing up or setting the table. These changes indicate a significant decline in social, academic, and occupational functioning.

Severe Cognitive Impairment

• In advanced stages, brain deterioration leads to severe cognitive impairment where patients fail to recognize family members or communicate effectively. They often speak incoherently and become completely dependent on others for daily activities like bathing or changing clothes. Weight loss is common due to neglecting self-care.

Terminal Stage Complications

• Patients in terminal stages are often bedridden for most of the day; they do not die from the primary illness but rather from complications such as aspiration pneumonia due to being unable to swallow properly or skin infections from prolonged immobility.

Cognitive Symptoms Overview

Clinical Symptoms and Diagnosis of Alzheimer's Disease

Clinical Manifestations

• The final stages of Alzheimer's disease include severe symptoms such as loss of recognition for family members, global apathy, hallucinations, and deterioration in mobility. Patients may become bedridden or reliant on wheelchairs.

• Severe stages can also involve convulsions. Clinical symptoms observed during examinations indicate a later stage of the disease, suggesting that amyloid-beta and tau proteins have accumulated over many years.

Cognitive Impairments

• Early alterations due to amyloid-beta accumulation manifest primarily as memory issues but can also affect language, attention, concentration, judgment, problem-solving abilities, and visuospatial functions.

• Cognitive decline is often classified using the Geriatric Depression Scale (GDS), where GDS7 indicates severe dementia based on clinical observations.

Diagnostic Process

• Diagnosis is primarily clinical; it involves interviewing patients and their families while also considering imaging tests and blood work to rule out secondary causes of dementia.

• Dementia types are categorized into primary (e.g., Alzheimer’s disease) caused by neurodegeneration and secondary types resulting from metabolic or cerebral alterations.

Exclusion Criteria

• Conditions like vitamin B12 deficiency or hypothyroidism must be ruled out since they can cause memory issues similar to those seen in Alzheimer's.

• If underlying conditions are treated effectively, patients may regain normal memory function.

Testing Methods

• Various cognitive assessments such as the Mini-Mental State Examination (MMSE), MoCA, and others are utilized alongside structural imaging techniques like CT scans or MRIs to evaluate brain atrophy.

• Biomarkers for amyloid-beta or tau proteins in cerebrospinal fluid are not routinely used due to high costs but can indicate an increased risk for developing Alzheimer’s if present.

Imaging Techniques in Alzheimer's Diagnosis

Importance of Imaging

• Imaging plays a crucial role in diagnosing Alzheimer’s by helping exclude other forms of dementia caused by tumors or hemorrhages.

Typical Findings

• Common imaging findings associated with Alzheimer’s include atrophy in specific brain regions such as the hippocampus and parietal lobes.

Advanced Imaging Insights

• MRI is particularly useful for assessing temporal lobe atrophy which is indicative of Alzheimer’s progression.

• Atrophy beyond normal aging patterns suggests significant cognitive impairment rather than typical age-related changes.

Understanding Atrophy in Alzheimer's Disease

Evaluating Atrophy Scales

• The discussion begins with the suspicion of a disease related to atrophy, emphasizing the need for specific scoring systems to determine if atrophy is normal or abnormal.

• Mention of various scales used to evaluate cortical atrophy, including the Global Cortical Atrophy (GCA) scale and others that assess parietal atrophy.

• Description of how different grades of atrophy are identified through imaging techniques like MRI, noting that even grade one shows signs of deepening sulci indicative of atrophy.

Severity and Imaging Techniques

• As severity increases (grade two and three), more pronounced signs of atrophy become visible on MRI scans, particularly in the temporal lobe and hippocampus.

• Advanced volumetric studies measure hippocampal volume against normalized scales to classify findings as normal or abnormal.

Mixed Dementia Considerations

• Discussion on mixed dementia, which can involve both Alzheimer’s disease and vascular dementia due to microinfarcts; visual examples are provided showing these microinfarcts on axial images.

Diagnostic Checklists and Functional Studies

• A checklist is introduced for diagnosing alterations seen in resonance imaging. Functional MRIs may also be utilized to assess brain activity based on substance uptake.

Biomarkers in Alzheimer's Diagnosis

• PET scans are highlighted for evaluating amyloid concentration, crucial for understanding which areas of the brain are functioning abnormally in Alzheimer’s patients.

Differentiating Alzheimer's from Other Conditions

Identifying Biomarkers

• Emphasis on identifying biomarkers such as beta-amyloid or tau proteins found in cerebrospinal fluid (CSF), which indicate excessive accumulation linked to Alzheimer’s disease.

Cost and Accessibility Issues

• Noted that tests for these biomarkers can be expensive and often limited to clinical research settings rather than routine diagnostics.

Differential Diagnosis Challenges

• Importance of differentiating Alzheimer’s from other conditions like depression, metabolic disorders, endocrine issues, infections, trauma-related problems, and various types of dementia.

Depression vs. Dementia Symptoms

• Clarification that symptoms can overlap between depression and dementia; distinguishing features include fluctuating memory issues typical in depression versus consistent memory loss seen in Alzheimer’s.

Treatment Approaches for Alzheimer's Disease

Advances in Treatment Options

Treatment Options for Memory Improvement

Pharmacological Treatments

• Anticholinesterase medications are introduced as treatments that improve memory function.

• Memantine is mentioned as another pharmacological option, categorized under anti-DM (diabetes mellitus) drugs.

Immunotherapy and Non-Pharmacological Approaches

• Immunotherapy is a new treatment aimed at directly addressing the accumulation of beta-amyloids, believed to be a primary cause of Alzheimer's disease.

• Non-pharmacological therapies are emphasized, highlighting modifiable risk factors such as smoking cessation, alcohol reduction, increased physical activity, and improved diet.

Lifestyle Modifications

• Good sleep hygiene is crucial; poor sleep is identified as a risk factor for dementia.

• Engaging with music can evoke memories even in advanced dementia cases; music therapy proves effective in stimulating recall.

Cognitive and Social Engagement

• Activities like memory games (e.g., Sudoku), social interaction, and family inclusion are vital to prevent isolation and depression in patients.

Comprehensive Treatment Strategies

• A range of medications may be used to manage symptoms: antidepressants for depression, anxiolytics for anxiety, antiepileptics for seizures, and neuroleptics for severe behavioral issues.

Specific Medications Explained

Cholinesterase Inhibitors

• Cholinesterase inhibitors enhance memory by increasing acetylcholine levels in the brain by inhibiting its degrading enzyme.

Memantine's Mechanism of Action

• Memantine operates differently from cholinesterase inhibitors; it targets NMDA receptors to prevent neurotoxicity caused by calcium accumulation.

Emerging Therapies: Immunotherapy

Current Developments

• New immunotherapies involve monoclonal antibodies designed to reduce beta-amyloid accumulation. Ecanemab and Donanemab are highlighted as current options available in the U.S.

Clinical Considerations

Understanding the Role of Anti-Amyloid Therapy in Dementia

Efficacy and Limitations of Anti-Amyloid Therapy

• The anti-amyloid therapy has shown potential in delaying disease progression in certain cases, particularly for patients with preclinical stages or mild dementia.

• This treatment is not applicable for patients with moderate to severe dementia, indicating a critical window for intervention.

Dietary Recommendations for Cognitive Health

• A Mediterranean diet is recommended, emphasizing fruits, nuts, white meat, and omega-3 fatty acids as beneficial components.

• Supplementation with folic acid and vitamin B12 is advised alongside managing hypertension to support cognitive function.

Lifestyle Modifications to Mitigate Dementia Risk

• Regular physical exercise and hydration are crucial; dehydration can lead to dizziness and orthostatic hypotension in patients.

• Avoiding sedentary lifestyles, alcohol consumption, smoking, and drug use is essential for reducing dementia risk factors. Additionally, sleep quality should be monitored as sleep disturbances can increase dementia risk.

Upcoming Seminars on Neurological Topics

Seminar Structure and Topics

• Two seminars will focus on "Status Epilepticus" (definition, classification, management) and "Anxiolytics," with students divided into groups for presentations. Each group will consist of six or seven members.

Presentation Guidelines

• Presentations should prioritize visual content over text; minimal text usage is encouraged to enhance engagement during discussions. Students should focus on understanding key concepts rather than memorizing dosages or extensive details about medications.

Key Learning Objectives

• For anxiolytics: Understand their purpose, mechanism of action, indications, adverse effects, and contraindications without delving into specific dosages.